medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2010, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (2)

Norwegian scabies. A case with a hospital outbreak of typical scabies cases

Quero HA, Sánchez NLM, Estrada CR, Sánchez DMA, Osorio AA

Language: Spanish
References: 21
Page: 136-140
PDF size: 202.93 Kb.


ABSTRACT

Introduction: Norwegian scabies is an atypical form of scabies, affecting immune-compromised patients, with hyperkeratotic lesions and is highly contagious.
Clinical case: A four year-old female patient, with acute lymphoblastic leukemia and a three day history of disseminated pruriginous, erithematous-scamous hyperkeratotic plaques. Sarcoptes scabiei was isolated from the lesions on a scrape and with an impronta. Treatment with ivermectin and benzylbenzoate was successful, with complete remission of the dermatosis.
Conclusion: Norwegian scabies represents a diagnostic challenge because of its atypical appearance. As it affects immunecompromised individuals, the high quantity of parasites in the lesions explains why it is highly contagious and the intra-hospitalary outbreak of typical cases of scabies.


REFERENCES

  1. López-Navarro CR. “Escabiosis en un paciente inmunosuprimido”. Rev Cent Dermatol Pascua 2005; 14(1): 35-38.

  2. Vásquez-Tsuji O, Campos-Rivera T, Durán-McKinster C, Romero-Rosas ME. “Escabiosis”. Acta Pediatr Mex 2006; 27(2): 73-83.

  3. Tay Zavala J, Lara Aguilera R, Velasco Castrejón O, Gutiérrez Quiroz M. Parasitología médica. 6ª ed. México, Méndez, Unidad XIV, “Artrópodos de importancia médica. Ácaros”, 1996, 419-428.

  4. Aubin F, Humbert P. “Ivermectin for crusted scabies (letter)”. N Engl J Med 1995; 332: 612.

  5. Carrada-Bravo T. “Sarna noruega”. Med Int Mex 2004; 20: 146-147.

  6. Fernández Tamayo N, Flores Villa R, Blanco Aguilar J, Dueñas Arau MA, Cristal Peña MP, Rubio Calva C y cols. “Sarna costrosa (noruega). Presentación de un caso clínico”. Gac Méd Méx 2006; 142(6): 507-510.

  7. Elgueta A, Parada EY, Guzmán GW, Molina CP, González AP. “Brote de sarna en un hospital terciario a partir de un caso de sarna costrosa”. Rev Chil Infect 2007; 24(4): 306-310.

  8. Fajardo-Velásquez R, Urdez-Hernández E, Ysita-Morales A. “Brote intrahospitalario de escabiasis a partir de un caso de sarna noruega”. Salud Pública Méx 2004; 46: 251-254.

  9. Díaz Maroto M. “Sarna y sarna noruega. Diagnóstico, prevención y tratamientos actuales”. Farm Hosp 1988; 22: 1-9.

  10. Mahé A, Prual A, Konaté M, Bobin P. “Skin diseases of children in Mali: A public health problem”. Trans R Soc Trop Med Hyg 1995; 89(5): 467- 470.

  11. Prens E, Hegmans J, Lien RC, Debets R, Troost R, van Joost T et al. “Increased expression of interleukin-4 receptors on psoriatic epidermal cells”. Am J Pathol 1996; 148: 1493-1502.

  12. Walton SF, Beroukas D, Roberts TP, Currie BJ. “New insights into disease pathogenesis in crusted (Norwegian) scabies: The skin immune response in crusted scabies”. Br J Dermatol 2008; 158(6): 1247-1255.

  13. Neste D, Lachapelle JM. “Host-parasite relationships in hyperkeratotic (Norwegian) scabies: Patohological and immunological findings”. B J Dermatol 1981; 105(6): 667-678.

  14. Comolli RR, Palacios A, Bartolini C. “Brote intrahospitalario de escabiosis a partir de un caso de sarna costrosa”. Revista del Hospital General de Agudos J.M. Ramos Mejía 2003; 8(2): edición electrónica.

  15. Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia-P JP, Martin PM. “Comparison of ivermectin and benzylbenzoate for treatement of scabies”. Trop Med Parasitol 1993; 44(4): 331-332.

  16. Arenas R, Ruiz-Esmenjaud J, Morales-Chávez CE, Ablanedo-Terrazas Y, Rodríguez-Álvarez M. “Ivermectina oral: Cinco años de experiencia. Presentación de 34 parasitosis cutáneas: Escabiasis, sarna costrosa, larva migrans, gnathostomiasis, pediculosis y demodecidosis”. DCMQ 2003; 1(1): 20-29.

  17. Macotela-Ruiz E, Peña-González G. “Tratamiento de la escabiasis con ivermectina por vía oral”. Gac Med Mex 1993; 129: 201-205.

  18. Scheinfeld N. “Controlling scabies in institutional settings: A review of medications, treatment models, and implementation”. Am J Clin Dermatol 2004; 5(1): 31-37.

  19. Buffet M, Dupin N. “Current treatments for scabies”. Fundam Clin Pharmacol 2003; 17(2): 217-225.

  20. Strong M, Johnstone PW. “Interventions for treating scabies”. Cochrane Database Syst Rev 2007; 18(3): CD000320.

  21. Fawcett RS. “Ivermectin use in scabies”. Am Fam Physician 2003; 68(6): 1089-1992.




2020     |     www.medigraphic.com